Biofrontera (BFRIW) Cash & Current Investments (2020 - 2025)

Biofrontera's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $6.4 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 8.41% year-over-year to $6.4 million; the TTM figure through Dec 2025 stood at $6.4 million (up 8.41% YoY), while the FY2025 annual figure was $6.4 million, up 8.41% from the prior year.
• Cash & Current Investments was $6.4 million for Q4 2025 at Biofrontera, up from $3.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $31.9 million in Q2 2022 to a low of $1.4 million in Q4 2023.
• Historically, Cash & Current Investments has averaged $11.1 million across 5 years, with a median of $6.4 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments jumped 1518.71% in 2022, then sank 94.88% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $24.5 million in 2021, then gained by 13.05% to $27.7 million in 2022, then tumbled by 94.88% to $1.4 million in 2023, then soared by 316.05% to $5.9 million in 2024, then climbed by 8.41% to $6.4 million in 2025.
• The last three Cash & Current Investments figures came in at $6.4 million (Q4 2025), $3.4 million (Q3 2025), and $7.2 million (Q2 2025), per Business Quant data.